These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38560638)

  • 1. Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Canzi CC; do Prado Júnior ER; da Silva Menezes Júnior A; Rezende AL; Botelho SM; Santos LDR
    Am Heart J Plus; 2022 Dec; 24():100229. PubMed ID: 38560638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: An updated comprehensive review and meta-analysis.
    da Silva Menezes A; Sanches MR; de Oliveira Filho E; de Oliveira EJR; Oliveira VMR; Moraes VRY
    Catheter Cardiovasc Interv; 2024 Jun; ():. PubMed ID: 39031814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
    Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
    Yang H; Yang Y; Xue Y; Luo S
    Clin Cardiol; 2020 May; 43(5):450-458. PubMed ID: 32034788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septal Ablation with Radiofrequency Catheters Guided by Echocardiography for Treatment of Patients with Obstructive Hypertrophic Cardiomyopathy: Initial Experience.
    Valdigem BP; Correia EB; Moreira DAR; Bihan DL; Pinto IMF; Abizaid AAC; Andalaft RB; Paladino Filho AT; Silva HAGPD; Viesi JHZ
    Arq Bras Cardiol; 2022 May; 118(5):861-872. PubMed ID: 35137775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
    Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
    J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
    Liu Q; Qiu H; Jiang R; Tang X; Guo W; Zhou K; Chen Q; Sun Y; Yu L; Chen S; Zhang P; Sheng X; Zhu J; Lin J; Cheng H; Wang Y; Wang B; Yu C; Mao Y; Zhang J; Zhang Z; Zei PC; Fu G; Jiang C
    Front Cardiovasc Med; 2021; 8():743044. PubMed ID: 34869646
    [No Abstract]   [Full Text] [Related]  

  • 9. From 100 to 0: Endocardial Radiofrequency Ablation of Septal Hypertrophy for Management of Hypertrophic Cardiomyopathy.
    Peigh G; Wasserlauf J; Choudhury L; Knight BP; Kim S
    JACC Case Rep; 2020 Jul; 2(8):1173-1177. PubMed ID: 34317442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.
    Zhou M; Ta S; Hahn RT; Hsi DH; Leon MB; Hu R; Zhang J; Zuo L; Li J; Wang J; Wang B; Zhu X; Liu J; Han Y; Li X; Xu B; Zhang L; Hou L; Han C; Liu J; Liu L
    JAMA Cardiol; 2022 May; 7(5):529-538. PubMed ID: 35353129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of 2D speckle tracking imaging in evaluating the effect of percutaneous intramyocardial septal radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy.
    Qian D; Zhou X; Liu H; Cao L
    J Clin Ultrasound; 2021 Jul; 49(6):554-562. PubMed ID: 33675543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
    Poon SS; Field M; Gupta D; Cameron D
    Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol septal ablation in patients with concomitant hypertrophic cardiomyopathy and aortic valvular stenosis.
    El-Sabawi B; Nishimura RA; Guerrero ME; Rihal CS; Eleid MF
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):830-837. PubMed ID: 31410979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis.
    Yokoyama Y; Shimoda T; Shimada YJ; Shimamura J; Akita K; Yasuda R; Takayama H; Kuno T
    Eur J Cardiothorac Surg; 2023 Mar; 63(3):. PubMed ID: 36782361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
    Alam M; Dokainish H; Lakkis NM
    Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center.
    Aguiar Rosa S; Fiarresga A; Galrinho A; Cacela D; Ramos R; de Sousa L; Gonçalves A; Bernardes L; Patrício L; Branco LM; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2019 Jul; 38(7):473-480. PubMed ID: 31495717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single Center Experience of Percutaneous Septal Ablation in Patients With Hypertrophic Cardiomyopathy With A Novel Agent: Polidocanol.
    Ateş AH; Şener YZ; Şahiner ML; Kaya EB; Aytemir K
    Am J Cardiol; 2023 Mar; 190():1-7. PubMed ID: 36535228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified endocardial radiofrequency ablation approach for hypertrophic obstructive cardiomyopathy guided by transthoracic echocardiography: a case series.
    Kong L; Zhao Y; Pan H; Ma J; Qian J; Ge J
    Ann Transl Med; 2021 Jun; 9(12):1006. PubMed ID: 34277806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a case report.
    Büchel J; Leibundgut G; Badertscher P; Kühne M; Krisai P
    Eur Heart J Case Rep; 2024 Aug; 8(8):ytae359. PubMed ID: 39108996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: technical review and long-term clinical and echocardiographic outcomes.
    Leal S; Galeote G; Jiménez-Valero S; Sánchez-Recalde A; Salinas P; Ruiz AS; Orbe LC; Dominguéz F; Moreno R; López-Sendón JL
    Rev Port Cardiol; 2012 May; 31(5):363-71. PubMed ID: 22482474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.